Evaluation of Efficacy and Tolerability of Hizentra®
NCT01354587
·
clinicaltrials.gov ↗
NA
Phase
UNKNOWN
Status
50
Enrollment
OTHER
Sponsor class
Conditions
Primary Immunodeficiency Disorders
Interventions
DRUG:
Hizentra
Sponsor
University of South Florida